Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKRO | Akero Therapeutics, Inc. | Jun 8, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 27, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
AKRO | Akero Therapeutics, Inc. | Jul 12, 2021 | 1 | $0 | 4 | Jul 14, 2021 | Director |
AKRO | Akero Therapeutics, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 14, 2021 | Director |